Ultragenyx Pharmaceutical, Inc. (RARE)
22.45
+1.03
(+4.81%)
USD |
NASDAQ |
Apr 02, 16:00
22.47
+0.02
(+0.09%)
Pre-Market: 20:00
Ultragenyx Pharmaceutical Profit Margin (Quarterly) : -62.32% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 11.83% |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Catalyst Pharmaceuticals, Inc. | 34.53% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Xencor, Inc. | -23.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -558.7% |
| Return on Assets | -42.04% |
| Return on Invested Capital | -54.16% |
| Gross Profit Margin (Quarterly) | 81.75% |
| Operating Margin (Quarterly) | -55.07% |
| Return on Net Operating Assets | -87.65% |